Immune checkpoint inhibitors stimulate the differentiation and proliferation of T cells, improve the function of CD8+ T cells, activate the body's autoimmune function, and enhance the recognition and cytotoxicity function of dendritic cells on tumor cells or tissues by triggering natural killer (NK) cells in mononuclear macrophages. The gene discussed is CD8A; the disease is neoplasm.